088 | Investigating the role of Hsp60 in the pathophysiology of celiac disease
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · 31.03.2026 · 99 (s1)
DOI: 10.4081/jbr.2026.15340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, online erschienen am 31.03.2026. Verfasst von Società Italiana di Biologia Sperimentale. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Celiac disease (CD) is a chronic immune-mediated disorder of the small intestine triggered by the ingestion of gluten in genetically predisposed individuals carrying the HLA-DQ2 and/or HLA-DQ8 haplotypes¹. It is characterized by CD4⁺ T cell–driven inflammation with release of pro-inflammatory cytokines (IFN-γ and IL-15¹), villous atrophy, impaired intestinal barrier function, and modulation by environmental factors such as infections, gut microbiota alterations, and coexisting autoimmune disorders [1]. In addition to the adaptive immune response induced by gluten, increasing evidence supports a role for innate immunity and cellular stress pathways in sustaining chronic intestinal inflammation in CD². Heat shock proteins (HSPs), particularly Hsp60, may act as molecular danger signals in inflammatory conditions and, when released extracellularly, can activate Toll-like receptor 4 (TLR4)–dependent NF-κB signaling, thereby promoting the transcription of pro-inflammatory mediators, immune cell recruitment, epithelial stress, and intestinal barrier dysfunction [2,3]. This study aimed to characterize the expression and potential role of Hsp60 in CD and its involvement in innate immunity activation. Duodenal biopsies from healthy controls and CD patients at different disease stages were analyzed by immunohistochemistry and immunofluorescence. Hsp60 expression increased in a stage-dependent manner from Marsh 0 to Marsh 3c, paralleling the increase in CD68-positive cells and showed marked co-localization between Hsp60 and CD68. TLR4 expression was also upregulated at all stages of the disease and strongly co-localized with Hsp60. Together, these findings suggest that Hsp60 may link epithelial stress to innate immune activation during CD progression, supporting a role for the Hsp60–TLR4 axis in mucosal inflammation and identifying Hsp60 as a potential therapeutic target.
Zitieren
APA
Sperimentale, S. I. D. B. (2026). 088 | Investigating the role of Hsp60 in the pathophysiology of celiac disease. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, 99(s1). https://doi.org/10.4081/jbr.2026.15340
Vancouver
Sperimentale SIDB. 088 | Investigating the role of Hsp60 in the pathophysiology of celiac disease. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 2026;99(s1). doi:10.4081/jbr.2026.15340
BibTeX
@article{Sperimentale2026,
author = {Sperimentale, Società Italiana di Biologia},
title = {088 | Investigating the role of Hsp60 in the pathophysiology of celiac disease},
journal = {Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale},
year = {2026},
volume = {99},
number = {s1},
doi = {10.4081/jbr.2026.15340}
}
EUVIMED